Waleed Danho
21Patents
6h-index
30Co-inventors
69Inventor score
Filing activity: Mar 30, 1987 → Sep 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6600015B2 | Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity | Human Necessities | 18 | Expired |
| US5182263A | Analogs of tyrosine sulfate or tyrosine phosphate containing peptides | Human Necessities | 17 | Expired |
| US5128448A | CCK analogs with appetite regulating activity | Chemistry; Metallurgy | 16 | Expired |
| US4808701A | Cyclic peptides having appetite regulating activity | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5296608A | Intermediates for analogs of tyrosine sulfate or tyrosine phosphate containing peptides | Human Necessities | 8 | Expired |
| US5508437A | Analogs of tyrosine sulfate or tyrosine phosphate containing peptides | Human Necessities | 8 | Expired |
| US7045591B2 | Selective cyclic peptides with melanocortin-4 receptor (MC4-R) agonist activity | Human Necessities | 4 | Expired |
| US5013722A | Cholecystokinin analogs for controlling appetite | Human Necessities | 4 | Expired |
| US4965343A | Method of peptide synthesis | Chemistry; Metallurgy | 4 | Expired |
| US7410949B2 | Neuropeptide-2 receptor (Y-2R) agonists and uses thereof | Human Necessities | 3 | Expired |
| US7642244B2 | Neuropeptide-2 receptor (Y-2R) agonists and uses thereof | Human Necessities | 2 | Active |
| US9416162B2 | Peptides having reduced toxicity that stimulate cholesterol efflux | Chemistry; Metallurgy | 1 | Active |
| US6080837A | Synthesis of VIP analog | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10774118B2 | Peptides having reduced toxicity that stimulate cholesterol efflux | Chemistry; Metallurgy | 0 | Active |
| US6316593A | Synthesis of VIP analog | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9023986B2 | Glucose-dependent insulinotropic peptide analogs | Human Necessities | 0 | Active |
| US8268784B2 | Neuropeptide-2 receptor (Y-2R) agonists and uses thereof | Human Necessities | 0 | Active |
| US11434267B2 | Peptides having reduced toxicity that stimulate cholesterol efflux | Chemistry; Metallurgy | 0 | Active |
| US10017551B2 | Peptides having reduced toxicity that stimulate cholesterol efflux | Chemistry; Metallurgy | 0 | Active |
| US9409961B2 | Cell penetrating peptides to target EIF4E | Chemistry; Metallurgy | 0 | Active |
| US8299023B2 | Neuropeptide-2 receptor (Y-2R) agonists | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.